We are live on ! Find out more
NRXP icon

NRX Pharmaceuticals
NRXP

19 hedge funds and large institutions have $41.4M invested in NRX Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more capital invested

Capital invested by funds: $39.2M → $41.4M (+$2.19M)

6% more funds holding

Funds holding: 18 → 19 (+1)

0.2% more ownership

Funds ownership: 4.53% → 4.73% (+0.2%)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.48M
2
RCM
Rivernorth Capital Management
Florida
+$1.78M
3
OAM
Oxford Asset Management
United Kingdom
+$1.26M
4
PC
Periscope Capital
Ontario, Canada
+$995K
5
HIM
HGC Investment Management
Ontario, Canada
+$503K

Top Sellers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
-$3.75M
2
BFM
Boothbay Fund Management
New York
-$2.36M
3
DAM
Deltec Asset Management
New York
-$732K
4
BI
Bulldog Investors
New Jersey
-$57.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
1
HGC Investment Management
Ontario, Canada
$4.72M +$503K +5,100 +12%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$4.64M +$370K +3,750 +9%
OAM
3
Oxford Asset Management
United Kingdom
$4.09M +$1.26M +12,764 +45%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$3.49M +$3.48M +35,239 New
BFM
5
Boothbay Fund Management
New York
$2.97M -$2.36M -23,953 -44%
KIM
6
Karpus Investment Management
New York
$2.51M +$14.1K +143 +0.6%
PC
7
Periscope Capital
Ontario, Canada
$2.5M +$995K +10,080 +67%
BI
8
Bulldog Investors
New Jersey
$2.44M -$57.6K -584 -2%
WCMNY
9
Westchester Capital Management (New York)
New York
$2.42M – – –
WRBC
10
W.R. Berkley Corp
Connecticut
$2.01M – – –
AA
11
AQR Arbitrage
Connecticut
$1.98M – – –
GCL
12
Glazer Capital LLC
New York
$1.91M +$3.16K +32 +0.2%
RCM
13
Rivernorth Capital Management
Florida
$1.78M +$1.78M +18,008 New
YCM
14
Yakira Capital Management
Connecticut
$1.64M – – –
KPF
15
K2 Principal Fund
Ontario, Canada
$1.45M – – –
BCM
16
Basso Capital Management
Connecticut
$531K – – –
HCMT
17
Highland Capital Management (Texas)
Texas
$271K +$270K +2,737 New
BCM
18
Bluefin Capital Management
New York
$36K – – –
UBS Group
19
UBS Group
Switzerland
$13K – – –
WAM
20
Weiss Asset Management
Massachusetts
– -$3.75M -38,140 Closed
DAM
21
Deltec Asset Management
New York
– -$732K -7,500 Closed

NRXP Hedge Fund Activity: Q2 2018 in Review

19 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q2 2018, worth a combined $41.4M — up 5.6% from $39.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NRXP positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $3.48M. The largest seller was Weiss Asset Management, exiting entirely with an estimated $3.75M sold.

  • 19 institutional investors held NRX Pharmaceuticals (NRXP) as of Q2 2018, up from 18 in Q1 2018.
  • Funds reported $41.4M of NRX Pharmaceuticals stock for Q2 2018, up 5.6% quarter-over-quarter.
  • 3 funds opened new NRX Pharmaceuticals positions in Q2 2018 and 2 closed out, a net change of +1 holder.
  • The largest NRX Pharmaceuticals buyer in Q2 2018 was Bank of Montreal, an estimated $3.48M added.
  • The largest NRX Pharmaceuticals seller in Q2 2018 was Weiss Asset Management, an estimated $3.75M sold.

Based on aggregated 13F filings for Q2 2018.